Gennex Laboratories

Gennex Laboratories Gross Margin

The Gross Margin of Gennex Laboratories (531739.BO) as of Oct 19, 2026 is 25.28 %. In the previous year, Gross Margin was 29.60 % — a change of -14.59% (lower).

Gross Margin

25.28 %

YoY

-14.59%

Last updated:

Gross Margin of Gennex Laboratories is 2026 25.28 % . Gross Margin of Gennex Laboratories was 2025 29.60 % . It decreases by -14.59% lower compared to the previous year.

Gennex Laboratories's gross margin stands at 25.3%, down from 37.8% several years earlier.

The Gennex Laboratories Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2019
41.41 INR
Jan 1, 2020
39.55 INR
Jan 1, 2021
40.12 INR
Jan 1, 2022
37.75 INR
Jan 1, 2023
39.16 INR
Jan 1, 2024
43.66 INR
Jan 1, 2025
29.60 INR
Jan 1, 2026
25.28 INR
The Gennex Laboratories Gross Margin history
YEARGross MarginYoY
25.28 %-14.59%
29.60 %-32.21%
43.66 %+11.50%
39.16 %+3.72%
37.75 %-5.89%
40.12 %+1.43%
39.55 %-4.48%
41.41 %+6.33%
38.94 %-9.24%
42.91 %-36.98%
68.08 %+167.26%
25.47 %+12.85%
22.57 %+11,385.28%
0.20 %-18.74%
0.24 %-7.29%
0.26 %-11.61%
0.30 %+18.06%
0.25 %+20.15%
0.21 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Gennex Laboratories Stock analysis

What does Gennex Laboratories do? Gennex Laboratories Ltd is a pharmaceutical manufacturer headquartered in Hyderabad, India, listed on the stock exchange in 1996. The company operates through its Pharmaceutical Products segment, specializing in the production of bulk drugs, intermediates, and biotech products. Its robust portfolio includes active pharmaceutical ingredients such as Guaifenesin, Methocarbamol, Phenazopyridine Hcl, Fluconazole, Mephenesin, Chlorphenesin, and Melitracen Hcl. These products serve various therapeutic areas, including expectorants, muscle relaxants, analgesics, anti-fungals, and antidepressants. Gennex Laboratories utilizes manufacturing facilities in India to supply both domestic and international markets, catering to the global demand for essential healthcare solutions within the health care sector. Gennex Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Gennex Laboratories stock

Gross Margin of Gennex Laboratories is 25.28 % in 2026.

Gross Margin of Gennex Laboratories changed from 29.60 % to 25.28 %, representing a -14.59% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Gennex Laboratories since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Gennex Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Gennex Laboratories

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Gennex Laboratories